

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 4.49076935 |
| 2 | cell migration in hindbrain (GO:0021535) | 4.44832399 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.35533483 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.31680526 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 4.30616397 |
| 6 | central nervous system myelination (GO:0022010) | 4.30616397 |
| 7 | cellular potassium ion homeostasis (GO:0030007) | 4.27298775 |
| 8 | positive regulation of dendritic spine development (GO:0060999) | 4.09130798 |
| 9 | protein localization to synapse (GO:0035418) | 4.05458940 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.03226654 |
| 11 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.00462361 |
| 12 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.99341162 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.97038998 |
| 14 | neuron recognition (GO:0008038) | 3.95930934 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 3.91448720 |
| 16 | auditory behavior (GO:0031223) | 3.90470544 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.85303213 |
| 18 | glutamate secretion (GO:0014047) | 3.81332413 |
| 19 | regulation of neurotransmitter levels (GO:0001505) | 3.81311912 |
| 20 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.74632391 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 3.72871946 |
| 22 | sodium ion export (GO:0071436) | 3.72492901 |
| 23 | positive regulation of membrane potential (GO:0045838) | 3.71620386 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.70937956 |
| 25 | L-amino acid import (GO:0043092) | 3.67649630 |
| 26 | axonal fasciculation (GO:0007413) | 3.67310577 |
| 27 | vocalization behavior (GO:0071625) | 3.67236862 |
| 28 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.58821888 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 3.56776235 |
| 30 | regulation of neurotransmitter transport (GO:0051588) | 3.56528504 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.54135163 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.45974540 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44082987 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 3.43750421 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.43368744 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 3.41556483 |
| 37 | membrane depolarization during action potential (GO:0086010) | 3.40251887 |
| 38 | establishment of mitochondrion localization (GO:0051654) | 3.39170071 |
| 39 | dendrite morphogenesis (GO:0048813) | 3.39141416 |
| 40 | dendritic spine organization (GO:0097061) | 3.37745211 |
| 41 | regulation of dendritic spine development (GO:0060998) | 3.35764618 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 3.34065591 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.28518363 |
| 44 | regulation of synapse maturation (GO:0090128) | 3.28388661 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.28171825 |
| 46 | regulation of cell communication by electrical coupling (GO:0010649) | 3.25667255 |
| 47 | response to auditory stimulus (GO:0010996) | 3.23982264 |
| 48 | neuromuscular process controlling balance (GO:0050885) | 3.20822005 |
| 49 | serotonin metabolic process (GO:0042428) | 3.20200595 |
| 50 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.19656304 |
| 51 | regulation of vesicle fusion (GO:0031338) | 3.18158008 |
| 52 | potassium ion import (GO:0010107) | 3.14272446 |
| 53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14207342 |
| 54 | * synaptic transmission (GO:0007268) | 3.14144659 |
| 55 | amino acid import (GO:0043090) | 3.13517451 |
| 56 | proline transport (GO:0015824) | 3.12926068 |
| 57 | acidic amino acid transport (GO:0015800) | 3.12715401 |
| 58 | behavioral defense response (GO:0002209) | 3.12486445 |
| 59 | behavioral fear response (GO:0001662) | 3.12486445 |
| 60 | prepulse inhibition (GO:0060134) | 3.11367926 |
| 61 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.10028496 |
| 62 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.08118559 |
| 63 | mitochondrion transport along microtubule (GO:0047497) | 3.08118559 |
| 64 | potassium ion homeostasis (GO:0055075) | 3.07727673 |
| 65 | phosphorelay signal transduction system (GO:0000160) | 3.07611050 |
| 66 | neurotransmitter secretion (GO:0007269) | 3.07206318 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06440540 |
| 68 | neuronal action potential (GO:0019228) | 3.06315722 |
| 69 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.05894358 |
| 70 | presynaptic membrane organization (GO:0097090) | 3.05878728 |
| 71 | presynaptic membrane assembly (GO:0097105) | 3.05688152 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05661228 |
| 73 | primary amino compound metabolic process (GO:1901160) | 3.05322904 |
| 74 | long-term memory (GO:0007616) | 3.05218048 |
| 75 | mechanosensory behavior (GO:0007638) | 3.04132715 |
| 76 | regulation of synapse structural plasticity (GO:0051823) | 3.03965080 |
| 77 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.03844669 |
| 78 | fear response (GO:0042596) | 3.02937868 |
| 79 | neuromuscular process controlling posture (GO:0050884) | 3.02725138 |
| 80 | adult walking behavior (GO:0007628) | 3.01011062 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00990229 |
| 82 | negative regulation of microtubule polymerization (GO:0031115) | 3.00966831 |
| 83 | regulation of synaptic transmission (GO:0050804) | 3.00578946 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00161637 |
| 85 | neurofilament cytoskeleton organization (GO:0060052) | 2.96125155 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 2.94172258 |
| 87 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.92669336 |
| 88 | detection of calcium ion (GO:0005513) | 2.92213503 |
| 89 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.89477589 |
| 90 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89290354 |
| 91 | locomotory exploration behavior (GO:0035641) | 2.88978471 |
| 92 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.87202700 |
| 93 | negative regulation of dendrite development (GO:2000171) | 2.85639605 |
| 94 | postsynaptic membrane organization (GO:0001941) | 2.85150537 |
| 95 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.84837073 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 2.82116204 |
| 97 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.81281246 |
| 98 | synaptic vesicle endocytosis (GO:0048488) | 2.81039819 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.80047224 |
| 100 | glutamate receptor signaling pathway (GO:0007215) | 2.78040021 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77498588 |
| 102 | response to pheromone (GO:0019236) | 2.76811334 |
| 103 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.76184930 |
| 104 | transmission of nerve impulse (GO:0019226) | 2.75103128 |
| 105 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.74793629 |
| 106 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.74793629 |
| 107 | cell communication involved in cardiac conduction (GO:0086065) | 2.73643727 |
| 108 | cell communication by electrical coupling (GO:0010644) | 2.71836666 |
| 109 | membrane depolarization (GO:0051899) | 2.71514869 |
| 110 | regulation of membrane repolarization (GO:0060306) | 2.69953043 |
| 111 | behavioral response to cocaine (GO:0048148) | 2.69662389 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.68199564 |
| 113 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.67067390 |
| 114 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.66695768 |
| 115 | axon extension (GO:0048675) | 2.66272437 |
| 116 | innervation (GO:0060384) | 2.66168722 |
| 117 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.65395563 |
| 118 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65360066 |
| 119 | neuronal ion channel clustering (GO:0045161) | 2.65213291 |
| 120 | synapse assembly (GO:0007416) | 2.63996405 |
| 121 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.63812106 |
| 122 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.63129652 |
| 123 | neuromuscular synaptic transmission (GO:0007274) | 2.62412934 |
| 124 | positive regulation of synapse maturation (GO:0090129) | 2.61826648 |
| 125 | hippocampus development (GO:0021766) | 2.61717749 |
| 126 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.58777723 |
| 127 | regulation of respiratory system process (GO:0044065) | 2.57281548 |
| 128 | regulation of neurotransmitter secretion (GO:0046928) | 2.54983455 |
| 129 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.54870627 |
| 130 | detection of temperature stimulus (GO:0016048) | 2.54400814 |
| 131 | neurotransmitter transport (GO:0006836) | 2.53711051 |
| 132 | synapse organization (GO:0050808) | 2.53528524 |
| 133 | regulation of postsynaptic membrane potential (GO:0060078) | 2.52895343 |
| 134 | negative regulation of axonogenesis (GO:0050771) | 2.51460230 |
| 135 | positive regulation of synapse assembly (GO:0051965) | 2.50432128 |
| 136 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.49992849 |
| 137 | mating behavior (GO:0007617) | 2.49629964 |
| 138 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.49549575 |
| 139 | exploration behavior (GO:0035640) | 2.49353043 |
| 140 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.47927941 |
| 141 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.47883696 |
| 142 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.47486056 |
| 143 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.47168522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.39208714 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.37234876 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99585054 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97076634 |
| 5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.95298161 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82177558 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72920071 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72920071 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70190382 |
| 10 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.48880532 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46165656 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45194729 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39979001 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39488563 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37280451 |
| 16 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33146300 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32784963 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30223737 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.18592831 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.18505790 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17795848 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12208900 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.97631354 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92875382 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89010816 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80600210 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74038998 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74037252 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73744118 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71715617 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69311488 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60147974 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57552305 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56339132 |
| 35 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55383218 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51581745 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49533368 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44964734 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44884888 |
| 40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43960732 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43501395 |
| 42 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42573313 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40924027 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39261402 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37957753 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31088541 |
| 47 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.29256929 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29032664 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28938428 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28637066 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26875832 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25902837 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20310308 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19684987 |
| 55 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.19593274 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18080400 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17073251 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15050834 |
| 59 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14959793 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14743144 |
| 61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12409561 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11459254 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10113001 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09677313 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07346042 |
| 66 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07236083 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.06853754 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03119655 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03119655 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02537196 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02302767 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02228699 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02110915 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00866198 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99126439 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98634752 |
| 77 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97373719 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96855446 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95821993 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95580061 |
| 81 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.94481985 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93795474 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93721118 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93115856 |
| 85 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91826910 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91658375 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91552066 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90889105 |
| 89 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90822234 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90685405 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89886374 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89766300 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89719318 |
| 94 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88980130 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88539354 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88283734 |
| 97 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88275184 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87918725 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86388154 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86225536 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85479006 |
| 102 | JUN_21703547_ChIP-Seq_K562_Human | 0.83027805 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82406203 |
| 104 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82168127 |
| 105 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82109490 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81744750 |
| 107 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.81434350 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79797585 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79316482 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79179965 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79174548 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.78629339 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78364567 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76275252 |
| 115 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75327550 |
| 116 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.74688235 |
| 117 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74568531 |
| 118 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.71072440 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.71009209 |
| 120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.70654157 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.70507593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.60760181 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.90808645 |
| 3 | MP0004270_analgesia | 3.80470891 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.18290761 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.05120626 |
| 6 | MP0002734_abnormal_mechanical_nocicepti | 2.83764137 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.77366912 |
| 8 | MP0002736_abnormal_nociception_after | 2.75722529 |
| 9 | MP0003787_abnormal_imprinting | 2.72415745 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.70616719 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.58974888 |
| 12 | MP0000751_myopathy | 2.33211919 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.32361416 |
| 14 | MP0000778_abnormal_nervous_system | 2.30247401 |
| 15 | MP0009745_abnormal_behavioral_response | 2.24041967 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.21536113 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.20913719 |
| 18 | MP0002272_abnormal_nervous_system | 2.15901738 |
| 19 | MP0002064_seizures | 2.12692235 |
| 20 | MP0001486_abnormal_startle_reflex | 2.04508424 |
| 21 | MP0004858_abnormal_nervous_system | 1.97448639 |
| 22 | MP0001970_abnormal_pain_threshold | 1.96253208 |
| 23 | MP0009046_muscle_twitch | 1.92687930 |
| 24 | MP0002184_abnormal_innervation | 1.91310920 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 1.91042839 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.79285441 |
| 27 | MP0003646_muscle_fatigue | 1.77246158 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.66366653 |
| 29 | MP0000955_abnormal_spinal_cord | 1.66196729 |
| 30 | MP0003122_maternal_imprinting | 1.65042588 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.62955431 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.57616157 |
| 33 | MP0003123_paternal_imprinting | 1.54347689 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.52218520 |
| 35 | MP0001529_abnormal_vocalization | 1.50484779 |
| 36 | MP0001984_abnormal_olfaction | 1.50478360 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.44896914 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.41756537 |
| 39 | MP0004142_abnormal_muscle_tone | 1.41034155 |
| 40 | MP0000749_muscle_degeneration | 1.40945854 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.40575163 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.39700177 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.37279523 |
| 44 | MP0003329_amyloid_beta_deposits | 1.36498681 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.35821453 |
| 46 | MP0004924_abnormal_behavior | 1.35821453 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.26210021 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.26168747 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.20451871 |
| 50 | MP0003121_genomic_imprinting | 1.18494647 |
| 51 | MP0001905_abnormal_dopamine_level | 1.17076480 |
| 52 | MP0004130_abnormal_muscle_cell | 1.15695943 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.15614250 |
| 54 | MP0004085_abnormal_heartbeat | 1.15169856 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.09574493 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.08715636 |
| 57 | MP0008872_abnormal_physiological_respon | 1.07537036 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.07273192 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.06477452 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.06255003 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.05794288 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.04498104 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.04146370 |
| 64 | MP0002152_abnormal_brain_morphology | 1.00944448 |
| 65 | MP0008569_lethality_at_weaning | 1.00075533 |
| 66 | MP0004147_increased_porphyrin_level | 0.99899177 |
| 67 | MP0005620_abnormal_muscle_contractility | 0.99458287 |
| 68 | MP0004133_heterotaxia | 0.98254809 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.98155613 |
| 70 | MP0004036_abnormal_muscle_relaxation | 0.97734786 |
| 71 | MP0003283_abnormal_digestive_organ | 0.97624393 |
| 72 | MP0001177_atelectasis | 0.97612745 |
| 73 | MP0002751_abnormal_autonomic_nervous | 0.96564059 |
| 74 | MP0005535_abnormal_body_temperature | 0.95565262 |
| 75 | MP0002229_neurodegeneration | 0.92398966 |
| 76 | MP0003690_abnormal_glial_cell | 0.91676730 |
| 77 | MP0000747_muscle_weakness | 0.88960714 |
| 78 | MP0002822_catalepsy | 0.88720879 |
| 79 | MP0004885_abnormal_endolymph | 0.86570909 |
| 80 | MP0000759_abnormal_skeletal_muscle | 0.86341446 |
| 81 | MP0004742_abnormal_vestibular_system | 0.85563290 |
| 82 | MP0004233_abnormal_muscle_weight | 0.84973117 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.84311106 |
| 84 | MP0002106_abnormal_muscle_physiology | 0.83216547 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.82149437 |
| 86 | MP0005499_abnormal_olfactory_system | 0.82149437 |
| 87 | MP0005083_abnormal_biliary_tract | 0.82009992 |
| 88 | MP0002269_muscular_atrophy | 0.81773830 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.80225409 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.78514533 |
| 91 | MP0003634_abnormal_glial_cell | 0.78373809 |
| 92 | MP0004087_abnormal_muscle_fiber | 0.78153224 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.77925325 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.77870865 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.77714568 |
| 96 | MP0004484_altered_response_of | 0.77633627 |
| 97 | MP0003938_abnormal_ear_development | 0.77593195 |
| 98 | MP0003631_nervous_system_phenotype | 0.76099772 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.76000327 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.75485636 |
| 101 | MP0005330_cardiomyopathy | 0.75287103 |
| 102 | MP0003633_abnormal_nervous_system | 0.75125929 |
| 103 | MP0003879_abnormal_hair_cell | 0.74084983 |
| 104 | MP0005369_muscle_phenotype | 0.73070126 |
| 105 | MP0000026_abnormal_inner_ear | 0.72989198 |
| 106 | MP0003861_abnormal_nervous_system | 0.72979845 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.72724472 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.72381438 |
| 109 | MP0002163_abnormal_gland_morphology | 0.72235255 |
| 110 | MP0000920_abnormal_myelination | 0.71012753 |
| 111 | MP0004084_abnormal_cardiac_muscle | 0.70362955 |
| 112 | MP0001188_hyperpigmentation | 0.69764634 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.68829997 |
| 114 | MP0009379_abnormal_foot_pigmentation | 0.67010120 |
| 115 | MP0002102_abnormal_ear_morphology | 0.65928546 |
| 116 | MP0003632_abnormal_nervous_system | 0.64771721 |
| 117 | MP0005187_abnormal_penis_morphology | 0.64401145 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.63361401 |
| 119 | MP0002160_abnormal_reproductive_system | 0.62471452 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.61087526 |
| 121 | MP0008874_decreased_physiological_sensi | 0.60455132 |
| 122 | MP0003119_abnormal_digestive_system | 0.60019701 |
| 123 | MP0005253_abnormal_eye_physiology | 0.59609461 |
| 124 | MP0001346_abnormal_lacrimal_gland | 0.59272455 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.57301110 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.55981059 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.55498344 |
| 128 | MP0005195_abnormal_posterior_eye | 0.52849404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.56664411 |
| 2 | Myokymia (HP:0002411) | 4.55551641 |
| 3 | Abnormality of binocular vision (HP:0011514) | 3.81016461 |
| 4 | Diplopia (HP:0000651) | 3.81016461 |
| 5 | Focal seizures (HP:0007359) | 3.63126347 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.49168690 |
| 7 | Atonic seizures (HP:0010819) | 3.40064162 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.38706873 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.38471610 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.19884639 |
| 11 | Sudden death (HP:0001699) | 3.15552347 |
| 12 | Ankle clonus (HP:0011448) | 3.15148333 |
| 13 | Febrile seizures (HP:0002373) | 3.12313123 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 3.01714982 |
| 15 | Hemiparesis (HP:0001269) | 2.87005328 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 2.84738866 |
| 17 | Visual hallucinations (HP:0002367) | 2.83068944 |
| 18 | Broad-based gait (HP:0002136) | 2.82692085 |
| 19 | Failure to thrive in infancy (HP:0001531) | 2.82306061 |
| 20 | Hyperventilation (HP:0002883) | 2.81544576 |
| 21 | Absence seizures (HP:0002121) | 2.79329012 |
| 22 | Polyphagia (HP:0002591) | 2.75197809 |
| 23 | Status epilepticus (HP:0002133) | 2.74259372 |
| 24 | Cerebral hypomyelination (HP:0006808) | 2.71457750 |
| 25 | Intention tremor (HP:0002080) | 2.70490150 |
| 26 | Annular pancreas (HP:0001734) | 2.70265365 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 2.68837244 |
| 28 | Pheochromocytoma (HP:0002666) | 2.65141822 |
| 29 | Termporal pattern (HP:0011008) | 2.64872506 |
| 30 | Insidious onset (HP:0003587) | 2.64872506 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.62720686 |
| 32 | Postural instability (HP:0002172) | 2.62636322 |
| 33 | Dialeptic seizures (HP:0011146) | 2.61842737 |
| 34 | Papilledema (HP:0001085) | 2.60047540 |
| 35 | Mutism (HP:0002300) | 2.56808553 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54340480 |
| 37 | Amblyopia (HP:0000646) | 2.53040152 |
| 38 | Spastic gait (HP:0002064) | 2.49865901 |
| 39 | Hemiplegia (HP:0002301) | 2.49836877 |
| 40 | Spastic tetraparesis (HP:0001285) | 2.42798399 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.42643404 |
| 42 | Urinary urgency (HP:0000012) | 2.40278708 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 2.38268514 |
| 44 | Action tremor (HP:0002345) | 2.36205944 |
| 45 | Truncal ataxia (HP:0002078) | 2.34576339 |
| 46 | Myoglobinuria (HP:0002913) | 2.31143526 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31044174 |
| 48 | Genetic anticipation (HP:0003743) | 2.27148995 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.27127316 |
| 50 | Prolonged QT interval (HP:0001657) | 2.26417014 |
| 51 | Gait imbalance (HP:0002141) | 2.26216096 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.25385559 |
| 53 | Craniofacial dystonia (HP:0012179) | 2.24521925 |
| 54 | Sleep apnea (HP:0010535) | 2.23540971 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.21731117 |
| 56 | Myotonia (HP:0002486) | 2.19741463 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.18722876 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.17874831 |
| 59 | Abnormality of the lower motor neuron (HP:0002366) | 2.17746025 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.16622183 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.15627123 |
| 62 | Tetraplegia (HP:0002445) | 2.15551333 |
| 63 | Exercise-induced muscle cramps (HP:0003710) | 2.14984463 |
| 64 | Clonus (HP:0002169) | 2.14743904 |
| 65 | EMG: myopathic abnormalities (HP:0003458) | 2.13547435 |
| 66 | Incomplete penetrance (HP:0003829) | 2.12080034 |
| 67 | Anxiety (HP:0000739) | 2.12030307 |
| 68 | Shoulder girdle muscle weakness (HP:0003547) | 2.11580417 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.10908376 |
| 70 | Epileptiform EEG discharges (HP:0011182) | 2.10506188 |
| 71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.10116972 |
| 72 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.10116972 |
| 73 | Esotropia (HP:0000565) | 2.08808961 |
| 74 | Hypoplasia of the brainstem (HP:0002365) | 2.08533687 |
| 75 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.08533687 |
| 76 | Type II lissencephaly (HP:0007260) | 2.07801364 |
| 77 | Abnormality of pain sensation (HP:0010832) | 2.07432113 |
| 78 | Impaired pain sensation (HP:0007328) | 2.07432113 |
| 79 | Depression (HP:0000716) | 2.06142111 |
| 80 | Abnormality of glycolysis (HP:0004366) | 2.05966374 |
| 81 | Increased serum pyruvate (HP:0003542) | 2.05966374 |
| 82 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05149024 |
| 83 | Dysmetria (HP:0001310) | 2.04916424 |
| 84 | Bradykinesia (HP:0002067) | 2.04468279 |
| 85 | Akinesia (HP:0002304) | 2.04221081 |
| 86 | Difficulty running (HP:0009046) | 2.03759878 |
| 87 | Medial flaring of the eyebrow (HP:0010747) | 2.03549841 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 2.03042540 |
| 89 | CNS hypomyelination (HP:0003429) | 2.03039551 |
| 90 | Poor eye contact (HP:0000817) | 2.02673312 |
| 91 | Drooling (HP:0002307) | 2.01786152 |
| 92 | Excessive salivation (HP:0003781) | 2.01786152 |
| 93 | Spastic tetraplegia (HP:0002510) | 2.01188516 |
| 94 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00425803 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.00392703 |
| 96 | Abnormal EKG (HP:0003115) | 1.99922776 |
| 97 | Ventricular fibrillation (HP:0001663) | 1.98333388 |
| 98 | Syncope (HP:0001279) | 1.94352157 |
| 99 | Megalencephaly (HP:0001355) | 1.93604838 |
| 100 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.93111366 |
| 101 | Agitation (HP:0000713) | 1.92364142 |
| 102 | Neurofibrillary tangles (HP:0002185) | 1.89506039 |
| 103 | Oligomenorrhea (HP:0000876) | 1.89462080 |
| 104 | Abnormal hair whorl (HP:0010721) | 1.87864059 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.86454157 |
| 106 | Limb dystonia (HP:0002451) | 1.86255704 |
| 107 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86241098 |
| 108 | Muscle fiber inclusion bodies (HP:0100299) | 1.85522940 |
| 109 | Abnormality of the labia minora (HP:0012880) | 1.85492280 |
| 110 | Inability to walk (HP:0002540) | 1.85435804 |
| 111 | Athetosis (HP:0002305) | 1.85211198 |
| 112 | Amyotrophic lateral sclerosis (HP:0007354) | 1.85139061 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 1.84438864 |
| 114 | Central scotoma (HP:0000603) | 1.83660299 |
| 115 | Bundle branch block (HP:0011710) | 1.83610545 |
| 116 | Abnormal social behavior (HP:0012433) | 1.83583866 |
| 117 | Impaired social interactions (HP:0000735) | 1.83583866 |
| 118 | Retinal dysplasia (HP:0007973) | 1.83511588 |
| 119 | Progressive macrocephaly (HP:0004481) | 1.80852367 |
| 120 | Muscle stiffness (HP:0003552) | 1.80811168 |
| 121 | Torticollis (HP:0000473) | 1.79897385 |
| 122 | Delusions (HP:0000746) | 1.79281142 |
| 123 | Hypoventilation (HP:0002791) | 1.78881097 |
| 124 | Impaired vibratory sensation (HP:0002495) | 1.78188411 |
| 125 | Lissencephaly (HP:0001339) | 1.77814022 |
| 126 | Absent speech (HP:0001344) | 1.77336008 |
| 127 | Acute encephalopathy (HP:0006846) | 1.77314001 |
| 128 | Focal dystonia (HP:0004373) | 1.75872749 |
| 129 | Pancreatic fibrosis (HP:0100732) | 1.75784192 |
| 130 | Nephronophthisis (HP:0000090) | 1.75575011 |
| 131 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.74832676 |
| 132 | Anosmia (HP:0000458) | 1.74572876 |
| 133 | Peripheral hypomyelination (HP:0007182) | 1.74392394 |
| 134 | Stereotypic behavior (HP:0000733) | 1.73894247 |
| 135 | Hypoplasia of the corpus callosum (HP:0002079) | 1.73796252 |
| 136 | True hermaphroditism (HP:0010459) | 1.73461025 |
| 137 | Ulnar claw (HP:0001178) | 1.73363437 |
| 138 | Primary atrial arrhythmia (HP:0001692) | 1.72051157 |
| 139 | Narrow nasal bridge (HP:0000446) | 1.71190575 |
| 140 | Specific learning disability (HP:0001328) | 1.71171099 |
| 141 | Split foot (HP:0001839) | 1.70155111 |
| 142 | Choreoathetosis (HP:0001266) | 1.70115306 |
| 143 | Molar tooth sign on MRI (HP:0002419) | 1.65796695 |
| 144 | Abnormality of midbrain morphology (HP:0002418) | 1.65796695 |
| 145 | Pancreatic cysts (HP:0001737) | 1.62355803 |
| 146 | Thyroid-stimulating hormone excess (HP:0002925) | 1.60515144 |
| 147 | Intellectual disability, severe (HP:0010864) | 1.60131218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.19314624 |
| 2 | MAP3K9 | 3.08039052 |
| 3 | PHKG1 | 2.73042416 |
| 4 | PHKG2 | 2.73042416 |
| 5 | CASK | 2.67104245 |
| 6 | MAP3K4 | 2.63784659 |
| 7 | NTRK3 | 2.57029974 |
| 8 | EPHA4 | 2.38363739 |
| 9 | MINK1 | 2.28573844 |
| 10 | MAP2K7 | 2.25511700 |
| 11 | CAMKK1 | 2.21993558 |
| 12 | PAK6 | 2.17153722 |
| 13 | MAP2K4 | 1.92010275 |
| 14 | MAPK13 | 1.88169237 |
| 15 | DAPK2 | 1.87883618 |
| 16 | NTRK2 | 1.85690922 |
| 17 | UHMK1 | 1.74729573 |
| 18 | CDK19 | 1.67576068 |
| 19 | NME1 | 1.61718045 |
| 20 | KSR1 | 1.45323231 |
| 21 | GRK5 | 1.43465673 |
| 22 | NTRK1 | 1.41114502 |
| 23 | DYRK2 | 1.40640257 |
| 24 | PRPF4B | 1.36187844 |
| 25 | BCR | 1.33933387 |
| 26 | STK39 | 1.32371125 |
| 27 | TNIK | 1.29341018 |
| 28 | CDK5 | 1.27104422 |
| 29 | OXSR1 | 1.26974589 |
| 30 | EPHB2 | 1.24391906 |
| 31 | PAK3 | 1.24183308 |
| 32 | SIK2 | 1.23620190 |
| 33 | LMTK2 | 1.19331106 |
| 34 | CAMKK2 | 1.18358159 |
| 35 | PINK1 | 1.18279236 |
| 36 | PKN1 | 1.11089890 |
| 37 | OBSCN | 1.10161358 |
| 38 | CSNK1G2 | 1.09691157 |
| 39 | LIMK1 | 1.09115349 |
| 40 | KSR2 | 1.08643151 |
| 41 | SGK223 | 1.07807179 |
| 42 | SGK494 | 1.07807179 |
| 43 | TYRO3 | 1.05591553 |
| 44 | IRAK2 | 1.05222011 |
| 45 | MAP3K12 | 0.98099431 |
| 46 | PRKCG | 0.97256399 |
| 47 | PLK2 | 0.97222325 |
| 48 | CSNK1G3 | 0.97185808 |
| 49 | DYRK1A | 0.95371729 |
| 50 | CAMK2A | 0.92497697 |
| 51 | FGFR2 | 0.91462837 |
| 52 | MAP3K13 | 0.89942920 |
| 53 | CDK14 | 0.86941846 |
| 54 | MAP3K11 | 0.86282172 |
| 55 | STK38 | 0.85206296 |
| 56 | WNK4 | 0.82504533 |
| 57 | PNCK | 0.82490864 |
| 58 | INSRR | 0.82218439 |
| 59 | CDK18 | 0.81816469 |
| 60 | WNK3 | 0.81122577 |
| 61 | LATS2 | 0.80032768 |
| 62 | STK11 | 0.79733201 |
| 63 | CAMK2B | 0.79048197 |
| 64 | BMPR2 | 0.78028017 |
| 65 | BRAF | 0.77133878 |
| 66 | CDK15 | 0.76461736 |
| 67 | RET | 0.75639397 |
| 68 | CSNK1A1L | 0.75196411 |
| 69 | ROCK2 | 0.75160681 |
| 70 | ADRBK2 | 0.74356166 |
| 71 | CDC42BPA | 0.74297208 |
| 72 | FGR | 0.74145437 |
| 73 | CSNK1G1 | 0.73999141 |
| 74 | AKT3 | 0.73942620 |
| 75 | PRKD3 | 0.72536972 |
| 76 | FRK | 0.70948988 |
| 77 | MAPK12 | 0.70946359 |
| 78 | ROCK1 | 0.68987116 |
| 79 | CAMK2D | 0.68076160 |
| 80 | ICK | 0.66499941 |
| 81 | TTN | 0.66375255 |
| 82 | PRKCE | 0.66022124 |
| 83 | CDK11A | 0.65335536 |
| 84 | DAPK3 | 0.65166218 |
| 85 | SGK2 | 0.63530212 |
| 86 | DMPK | 0.61743205 |
| 87 | CAMK2G | 0.60338028 |
| 88 | FER | 0.60297810 |
| 89 | MARK2 | 0.58726432 |
| 90 | SGK3 | 0.58166027 |
| 91 | NEK1 | 0.58090656 |
| 92 | ALK | 0.57686321 |
| 93 | TAOK3 | 0.57521807 |
| 94 | PRKCZ | 0.57302022 |
| 95 | RIPK4 | 0.57278662 |
| 96 | TNK2 | 0.54443680 |
| 97 | ERBB2 | 0.54240477 |
| 98 | CAMK4 | 0.54171132 |
| 99 | ADRBK1 | 0.52764078 |
| 100 | PRKAA1 | 0.52624867 |
| 101 | TLK1 | 0.51366523 |
| 102 | PRKACA | 0.50376635 |
| 103 | SGK1 | 0.50167722 |
| 104 | RPS6KA3 | 0.49098023 |
| 105 | GRK7 | 0.49036818 |
| 106 | MAP2K6 | 0.48197184 |
| 107 | MAP2K1 | 0.47861551 |
| 108 | MAP3K7 | 0.47237665 |
| 109 | MAPK10 | 0.46713852 |
| 110 | MAP3K6 | 0.46696298 |
| 111 | CAMK1 | 0.44940043 |
| 112 | GRK1 | 0.43731543 |
| 113 | DAPK1 | 0.43697488 |
| 114 | PTK2B | 0.43498352 |
| 115 | BRSK1 | 0.42693340 |
| 116 | PRKCA | 0.42373553 |
| 117 | TRIM28 | 0.42198333 |
| 118 | DDR2 | 0.41527983 |
| 119 | ARAF | 0.41508847 |
| 120 | CAMK1D | 0.41235722 |
| 121 | PRKCH | 0.40769501 |
| 122 | FES | 0.40114840 |
| 123 | WNK1 | 0.39860361 |
| 124 | BMPR1B | 0.39800532 |
| 125 | NEK6 | 0.36582078 |
| 126 | CSNK1A1 | 0.36044564 |
| 127 | BCKDK | 0.34933163 |
| 128 | PRKCI | 0.31893494 |
| 129 | STK16 | 0.31438155 |
| 130 | PDK1 | 0.31109934 |
| 131 | CSNK1D | 0.30807735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.88322683 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56079743 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.30310250 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.26694944 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.25447667 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21882212 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.13518742 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94153290 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.93061186 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.89219508 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.80615004 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78410472 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71519353 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69829220 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68601855 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67363732 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66632997 |
| 18 | Axon guidance_Homo sapiens_hsa04360 | 1.66078179 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64089438 |
| 20 | * Insulin secretion_Homo sapiens_hsa04911 | 1.62119393 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54886856 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52915052 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49396871 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48441009 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47554609 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40559330 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39909929 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39539078 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.35930747 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34178722 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.32501437 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31781863 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.25663395 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25324343 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22654775 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17977008 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16192443 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15823399 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15775160 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14994553 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14968679 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.12979383 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12327794 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10490573 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.08099084 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03926230 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.03813849 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02649342 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00791704 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00301509 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99473970 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98409103 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98212523 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96026284 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94675643 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.92591428 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92498860 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 0.91788663 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90819729 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90178725 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88630808 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88459848 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87836618 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84897459 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84310982 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84115107 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79729505 |
| 68 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.77147510 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75911705 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.75774592 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75644035 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74547705 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73406155 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71449279 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70929959 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70191892 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68760018 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67568454 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67346583 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67058071 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64826911 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58173318 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56433338 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55725394 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55480554 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54828424 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54636955 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54324961 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53556807 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53448203 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51766050 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51644679 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51549599 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48990680 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47659258 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.46914543 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46782839 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45980479 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44748165 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44642255 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44627311 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44313953 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43952588 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43191101 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42703230 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40352364 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38642469 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38429251 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37909162 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.36632324 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36528265 |
| 112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35435812 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.35105995 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34631533 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34544277 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34055379 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33975201 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33928213 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33742349 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33657121 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33121404 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32236736 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30396771 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25019399 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23575828 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20373678 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18145744 |

